ArticleESMO open2024

Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trial.

E Scanlon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.